Cellectar Biosciences Files Definitive Proxy Statement
Ticker: CLRB · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1279704
| Field | Detail |
|---|---|
| Company | Cellectar Biosciences, Inc. (CLRB) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Cellectar Proxy Statement filed. Vote on June 13th matters.
AI Summary
Cellectar Biosciences, Inc. filed its definitive proxy statement on April 28, 2025, for its annual meeting on June 13, 2025. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. The company, previously known as Novelos Therapeutics, Inc. and Common Horizons Inc., is in the pharmaceutical preparations industry.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the upcoming annual meeting and provides information necessary for them to cast their votes on important company matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating any immediate financial or operational distress.
Key Players & Entities
- Cellectar Biosciences, Inc. (company) — Registrant
- June 13, 2025 (date) — Annual Meeting Date
- April 28, 2025 (date) — Filing Date
- Novelos Therapeutics, Inc. (company) — Former Company Name
- Common Horizons Inc (company) — Former Company Name
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to solicit proxies from shareholders of Cellectar Biosciences, Inc. for their annual meeting.
When is the shareholder meeting scheduled to take place?
The shareholder meeting is scheduled for June 13, 2025.
What is the filing date of this proxy statement?
The definitive proxy statement was filed on April 28, 2025.
What were Cellectar Biosciences' former company names?
Cellectar Biosciences, Inc. was formerly known as Novelos Therapeutics, Inc. and Common Horizons Inc.
What is the Standard Industrial Classification (SIC) code for Cellectar Biosciences?
The SIC code for Cellectar Biosciences is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Cellectar Biosciences, Inc. (CLRB).